Search
for
Sort by
Research 751–780 of 1000+
- Loose anagen hair syndrome in children of Upper Egypt
- A rare pediatric case of loose anagen hair syndrome
- Loose Anagen Hair Syndrome in an Indian Child with Trichoscopic Features
- Loose Anagen Syndrome
- Anagen Effluvium after Therapeutic Scalp Surgery: Unreported Phenomenon
- On the Effect of Estrogen Receptor Agonists and Antagonists on the Mouse Hair Follicle Cycle
- Roles of MED1 in Quiescence of Hair Follicle Stem Cells and Maintenance of Normal Hair Cycling
- An Overview of Alopecias
- Identification of factors contributing to phenotypic divergence via quantitative image analyses of autosomal recessive woolly hair/hypotrichosis with homozygous c.736T>A<i>LIPH</i>mutation
- Tratamento bem sucedido de síndrome dos cabelos anágenos frouxos: um relato de caso
- Reply from the Authors
- Reply from the Authors
- Dermatological manifestations associated with COVID‐19: A comprehensive review of the current knowledge
- Mesotherapy and platelet-rich plasma for the treatment of hair loss
- Hair Loss in Women
- HAIR MATRIX CELL KINETICS: A SELECTIVE REVIEW
- Drug induced hair loss.
- Nonscarring hair loss disorders
- Hereditary, Congenital, and Acquired Alopecias
- Electron paramagnetic resonance (EPR) spectroscopy for investigating murine telogen skin after spontaneous or depilation-induced hair growth
- Clinical, Microscopic and Ultrastructural Findings in a Case of Short Anagen Syndrome
- Anagen effluvium
- Loose anagen hair syndrome
- Chemotherapy-Induced Anagen Effluvium: Diffuse or Patterned?
- Short anagen syndrome
- Short anagen syndrome: Case series and literature review
- Loose Anagen Hair Syndrome in Black‐Haired Indian Children
- The Thyroid Hormone Analogue KB2115 (Eprotirome) Prolongs Human Hair Growth (Anagen) Ex Vivo
- Thyroid Hormones Directly Alter Human Hair Follicle Functions: Anagen Prolongation and Stimulation of Both Hair Matrix Keratinocyte Proliferation and Hair Pigmentation
- Promotion of anagen, increased hair density and reduction of hair fall in a clinical setting following identification of FGF5-inhibiting compounds via a novel 2-stage process